1.
1
Ferlay J
, Bray F
, Parkin DM
, Pisani P
.
Globocan 2000: Cancer Incidence and Mortality Worldwide. IARC Cancer Bases No. 5
. Lyon: IARC Press; 2001;
.
2.
2
Lau M
, Le A
, El-Serag HB
.
Noncardia gastric adenocarcinoma remains an important and deadly cancer in the United States: secular trends in incidence and survival
.
Am J Gastroenterol
. 2006;101:2485–2492
.
MEDLINE
3.
3
Turan T, Aykan B, Koc S, Boran N, Tulunay G, Karacay O, et al
Analysis of metastatic ovarian tumors from extragenital primary sites
.
Tumori
. 2006;92:491–495
.
MEDLINE
4.
4
Kakushima N, Kamoshida T, Hirai S, Hotta S, Hirayama T, Yamada J, et al
Early gastric cancer with Krukenberg tumor and review of cases of intramucosal gastric cancers with Krukenberg tumor
.
J Gastroenterol
. 2003;38:1176–1180
.
MEDLINE |
CrossRef
5.
5
Grignon DJ
, Shum DT
, Hayman WP
.
Metastatic tumours of the testes
.
Can J Surg
. 1986;29:359–361
.
6.
6
Kaufman DS
, Saksena MA
, Young RH
, Tabatabaei S
.
Case records of the Massachusetts General Hospital. Case 6-2007. A 28-year-old man with a mass in the testis
.
N Engl J Med
. 2007;356:842–849
.
CrossRef
7.
7
Dutt N
, Bates AW
, Baithun SI
.
Secondary neoplasms of the male genital tract with different patterns of involvement in adults and children
.
Histopathology
. 2000;37:323–331
.
MEDLINE |
CrossRef
8.
8
Haupt HM
, Mann RB
, Trump DL
, Abeloff MD
.
Metastatic carcinoma involving the testis. Clinical and pathologic distinction from primary testicular neoplasms
.
Cancer
. 1984;54:709–714
.
9.
9
Qazi HA
, Manikandan R
, Foster CS
, Fordham MV
.
Testicular metastasis from gastric carcinoma
.
Urology
. 2006;68:890;
.
Abstract | Full Text |
Full-Text PDF (1336 KB)
10.
10
Niehans GA
, Manivel JC
, Copland GT
, Scheithauer BW
, Wick MR
.
Immunohistochemistry of germ cell and trophoblastic neoplasms
.
Cancer
. 1988;62:1113–1123
.
11.
11
Iczkowski KA
, Butler SL
.
New immunohistochemical markers in testicular tumors
.
Anal Quant Cytol Histol
. 2006;28:181–187
.
MEDLINE
12.
12
Shah MA
, Schwartz GK
.
Treatment of metastatic esophagus and gastric cancer
.
Semin Oncol
. 2004;31:574–587
.
Abstract | Full Text |
Full-Text PDF (159 KB)
|
CrossRef
13.
13
Ajani JA
.
Evolving chemotherapy for advanced gastric cancer
.
Oncologist
. 2005;10:49–58
.
CrossRef
14.
14
Sulkes A, Smyth J, Sessa C, Dirix LY, Vermorken JB, Kaye S, et al
Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group
.
Br J Cancer
. 1994;70:380–383
.
MEDLINE
15.
15
Roth AD, Maibach R, Martinelli G, Fazio N, Aapro MS, Pagani O, et al
Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO)
.
Ann Oncol
. 2000;11:301–306
.
MEDLINE |
CrossRef
16.
16
Ohtsu A, Boku N, Tamura F, Muro K, Shimada Y, Saigenji K, et al
An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer
.
Am J Clin Oncol
. 1998;21:416–419
.
MEDLINE |
CrossRef
17.
17
Dank M, Zaluski J, Barone C, Valvere V, Yalcin S, Peschel C, et al
Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction
.
Ann Oncol
. 2008;19:1450–1457
.
CrossRef
18.
18
Ajani AJ, Fodor MB, Tjulandin SA, Moiseyenko VM, Chao Y, Filho SC, et al
Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma
.
J Clin Oncol
. 2005;23:5660–5667
.
CrossRef